Table 1 Patient characteristics
All (n = 27) | GLIMGLIN | P | ||
|---|---|---|---|---|
Success (n = 13) | Failure (n = 14) | |||
Age, years | 77.4 ± 8.5 | 74.5 ± 7.6 | 80.0 ± 8.6 | 0.14 |
Male, n (%) | 20 (74.1) | 11 (84.6) | 9 (64.3) | 0.24 |
Body mass index, kg/m2 | 21.9 ± 3.7 | 21.5 ± 4.0 | 22.3 ± 3.4 | 0.42 |
Hypertension, n (%) | 26 (96.3) | 12 (92.3) | 14 (100) | 0.30 |
Dyslipidemia, n (%) | 15 (55.6) | 4 (30.8) | 11 (78.6) | 0.01* |
Diabetes, n (%) | 13 (48.1) | 6 (46.2) | 7 (50.0) | 0.85 |
Smoking, n (%) | 25 (92.6) | 12 (92.3) | 13 (92.9) | 0.96 |
Coronary artery disease, n (%) | 8 (29.6) | 4 (30.8) | 5 (35.7) | 0.79 |
Cerebrovascular disease, n (%) | 7 (25.9) | 2 (15.4) | 5 (35.7) | 0.24 |
Atrial fibrillation, n (%) | 7 (25.9) | 3 (23.1) | 4 (28.6) | 0.75 |
Heart failure, n (%) | 8 (29.6) | 4 (30.8) | 4 (28.6) | 0.90 |
eGFR < 60, n (%) | 18 (66.7) | 8 (61.5) | 10 (71.4) | 0.59 |
Haemodialysis, n (%) | 3 (11.1) | 1 (7.7) | 2 (14.3) | 0.59 |
Rutherford classification | ||||
2,3 | 13 (48.1) | 8 (61.5) | 6 (42.9) | 0.34 |
4 | 7 (25.9) | 1 (7.7) | 5 (35.7) | 0.09 |
5,6 | 7 (25.9) | 4 (30.8) | 3 (21.4) | 0.59 |